Medico Intercontinental Ltd

Medico Intercontinental Limited will hold a board meeting on November 6, 2026, at its registered office in Ahmedabad to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, and other business items, according to a regulatory filing with the BSE Limited. The trading window for designated persons and insiders has been closed since September 30, 2026, and will remain closed until 48 hours after the financial results are declared.

Medico Intercontinental Limited, BSE Scrip Code 539938, submitted a confirmation certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as processed by Purva Sharegistry (India) Pvt. Ltd.

Medico Intercontinental Limited informed the BSE Limited that the trading window for dealing in the company's securities will be closed from October 1, 2026, for designated persons and their immediate relatives until 48 hours after the declaration of the un-audited financial results for the quarter and half year ended September 30, 2026.

Medico Intercontinental Limited informed the BSE Limited and CSE - India that its Board of Directors decided to convene the Annual General Meeting on Wednesday, 30th September 2026 at 02:00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM), with the Register of Transfer and Register of Members to remain closed from September 24th, 2026 to September 30th, 2026, and a Record Date for E-Voting set for Wednesday, 23rd September 2026.

Medico Intercontinental Ltd share price softened by 1.27% to Rs 28.01 after the company's net profit jumped 73.19% to Rs 4.07 crore, while revenue from operations eased by 7.91% to Rs 20.71 crore in Q2FY26 over Q1FY26. The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 49691.37 crore, falling 11.57%. It has slipped by 0.67% over last one week and jumped by 24.91% in last one month while the market capitalization of Medico Intercontinental Ltd has eased by 3.35% and 21.84% in the same period respectively. Profit before tax (PBT) of Medico Intercontinental Ltd stood at Rs 3.68 crore in Q2 FY26, surging by 83.08% year-on-year, and rallying 137.42% quarter-on-quarter. EBITDA came in at Rs 1 crore, nosediving by 300.00% YoY and plunging by 154.67% sequentially. Total expenses posted a minor rise of 1.39% to Rs 22.61 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 2.79 crore, advancing by 18.72% YoY, while employee benefits expense was at Rs 2.56 crore, soaring 13.78% YoY. For the TTM ended FY26, revenue from operations surged 33.58% to Rs 95.32 crore, while net profit saw a strong growth of 25.57% to Rs 4.96 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 492% to Rs 7.77 crore, and PBT witnessed a strong rise of 25.37% to Rs 6.82 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 7.11 crore in FY26, as against Rs 5.58 crore in FY25. Medico Intercontinental Ltd nosedived by 22.06% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.

Medico Intercontinental Limited will hold a board meeting on Friday, August 14, 2026, at its registered office in Ahmedabad to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, and other business items, while the trading window for designated persons and insiders remains closed from June 30, 2026, until 48 hours after the financial results are declared.

Net loss of Medico Intercontinental reported to Rs 0.65 crore in the quarter ended March 2026 as against net profit of Rs 1.17 crore during the previous quarter ended March 2025. Sales rose 6.29% to Rs 22.49 crore in the quarter ended March 2026 as against Rs 21.16 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 3.20 crore in the year ended March 2026 as against net profit of Rs 5.06 crore during the previous year ended March 2025. Sales declined 11.79% to Rs 84.08 crore in the year ended March 2026 as against Rs 95.32 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales22.4921.16 6 84.0895.32 -12 OPM %7.169.17 -3.548.58 - PBDT-0.131.75 PL -3.917.61 PL PBT-1.551.47 PL -9.346.82 PL NP-0.651.17 PL -3.205.06 PL Powered by Capital Market - Live

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Net loss of Medico Intercontinental reported to Rs 0.22 crore in the quarter ended December 2025 as against net profit of Rs 1.17 crore during the previous quarter ended December 2024. Sales rose 7.70% to Rs 19.85 crore in the quarter ended December 2025 as against Rs 18.43 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales19.8518.43 8 OPM %8.0110.31 - PBDT0.031.80 -98 PBT-1.401.57 PL NP-0.221.17 PL Powered by Capital Market - Live

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live